Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  The Journal of Heart and Lung Transplantation

• Publication date

  1996-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 8889983
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation.

  1995cited by this paper
• Cytomegalovirus and rejection.

  1994cited by this paper
• The interaction of immunosuppression with infection in the organ transplant recipient.

  1994cited by this paper
• Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells.

  1994cited by this paper
• A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group.

  1994cited by this paper
• Combination antiviral strategies in managing cytomegalovirus infection.

  1994cited by this paper
• Evidence for an immunosuppressive activity of ganciclovir.

  1994cited by this paper
• Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients ‐ A meta‐analysis

  1994cited by this paper
• Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients.

  1994cited by this paper
• Causes of death in lung transplant recipients.

  1994cited by this paper
• Soluble TNF receptors (TNF-sR55 and TNF-sR75) in lung allograft recipients displaying cytomegalovirus pneumonitis.

  1994cited by this paper
• A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.

  1994cited by this paper
• Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat.

  1994cited by this paper
• Advances in understanding cytomegalovirus infection after transplantation.

  1994cited by this paper
• Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group.

  1993cited by this paper
• Prophylaxis and management of cytomegalovirus pneumonitis after lung transplantation: a review of experience in one center.

  1993cited by this paper
• A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation.

  1993cited by this paper
• Outcomes of lung transplantation using three different cytomegalovirus prophylactic regimens.

  1993cited by this paper
• Cytomegalovirus immediate early genes prevent the inhibitory effect of cyclosporin A on interleukin 2 gene transcription.

  1992cited by this paper
• A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation.

  1992cited by this paper
• Risk factors for cytomegalovirus pneumonia following allogeneic bone marrow transplantation after prophylaxis with intravenous immunoglobulin.

  1992cited by this paper
• Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients.

  1992cited by this paper
• Treatment of cytomegalovirus pneumonia in transplant patients.

  1991cited by this paper
• Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation.

  1991cited by this paper
• The immediate early genes of human cytomegalovirus upregulate expression of the interleukin-2 and interleukin-2 receptor genes.

  1991cited by this paper
• A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation.

  1990cited by this paper
• Treatment of cytomegalovirus disease.

  1990cited by this paper
• Virologic and pathogenetic aspects of cytomegalovirus infection.

  1990cited by this paper
• Intravenous immune globulin prophylaxis in recipients of a marrow transplant.

  1989cited by this paper
• Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin.

  1988cited by this paper
• Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants.

  1988cited by this paper
• Progress in the treatment of cytomegalovirus pneumonia.

  1988cited by this paper

• Pediatric Lung Transplantation

  2019cites this paper
• Long-Term Impact of Cytomegalovirus Serologic Status on Lung Transplantation in the United States.

  2019cites this paper
• Prevention of chronic rejection after lung transplantation.

  2017cites this paper
• Pediatric Lung Transplantation

  2017cites this paper
• Editorial Commentary: Chronic Lung Allograft Dysfunction in Lung Transplant Recipients: Another Piece of the Puzzle.

  2016influential citation
• Pulmonary Complications of Stem Cell and Solid Organ Transplantation

  2015cites this paper
• CMV management in lung transplant recipients

  2014cites this paper
• The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.

  2014cites this paper
• Late Respiratory Infection after Lung Transplantation

  2013cites this paper
• The Role of Infections in BOS

  2013cites this paper
• Pneumonia relevant to lung transplantation and pathogen distribution

  2013cites this paper
• Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis

  2012cites this paper
• Bronchiolitis Obliterans Syndrome

  2012cites this paper
• Pediatric Lung Transplantation

  2011cites this paper
• DNA viruses (CMV, EBV, and the herpesviruses).

  2011cites this paper
• DNA Viruses (CMV, EBV, and the Herpesviruses)

  2011cites this paper
• Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis.

  2010cites this paper
• Valganciclovir for the prevention and treatment of CMV in solid organ transplant recipients

  2010cites this paper
• Viral infections in lung transplant recipients.

  2010cites this paper
• Viral Infections in Lung Transplant Recipients

  2010cites this paper
• Year : 2008 Ganciclovir / valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation

  2009influential citation
• A Multicenter Study of Valganciclovir Prophylaxis up to Day 120 in CMV‐Seropositive Lung Transplant Recipients

  2009cites this paper
• Lung and heart-lung transplantation

  2009cites this paper
• Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation.

  2008influential citation
• Cytomegalovirus prevention in high-risk lung transplant recipients: comparison of 3- vs 12-month valganciclovir therapy.

  2008cites this paper
• Spezielle Therapieformen

  2008cites this paper
• Benefits of CMV Prophylaxis in Solid Organ Transplantation

  2007cites this paper
• Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation.

  2007cites this paper
• Studies on the impact of bronchoscopy in the diagnosis of respiratory infections and detection of viral infections in blood and bronchoalveolar lavage fluid

  2007cites this paper
• Pneumonia After Lung Transplantation in the Resitra Cohort: A Multicenter Prospective Study

  2007cites this paper
• Towards individualized controlled drug exposure in renal transplantation

  2007cites this paper
• Determination of ganciclovir in different matrices from solid organ transplanted patients treated with a wide range of concomitant drugs.

  2007cites this paper
• Infección en el trasplante de pulmón

  2007cites this paper
• Invited commentary.

  2006cites this paper
• RESPIRATORY VIRAL INFECTION IN OAD 2006;82:1043–51 GENERAL THORACIC

  2006cites this paper
• Respiratory viral infection in obliterative airway disease after orthotopic tracheal transplantation.

  2006cites this paper
• Bronchiolitis obliterans following lung transplantation.

  2006cites this paper
• Emergence of Multiple Cytomegalovirus Strains in Blood and Lung of Lung Transplant Recipients

  2006cites this paper
• Critical Care Perspective on Immunotherapy in Lung Transplantation

  2006cites this paper
• LUNG AND HEART-LUNG TRANSPLANTATION

  2006cites this paper
• Infections after lung transplantation.

  2006cites this paper
• A Trial of Valganciclovir Prophylaxis for Cytomegalovirus Prevention in Lung Transplant Recipients

  2005cites this paper
• Preemptive therapy with intravenous ganciclovir for the prevention of cytomegalovirus disease in lung transplant recipients.

  2005cites this paper
• Lung transplantation: a decade of experience.

  2005cites this paper
• Recomendaciones GESITRA-SEIMC y RESITRA sobre prevención y tratamiento de la infección por citomegalovirus en pacientes trasplantados

  2005cites this paper
• Cytomegalovirus pneumonia in transplant recipients.

  2005cites this paper
• Extended ganciclovir prophylaxis in lung transplantation.

  2005cites this paper
• Management of Cytomegalovirus Infection in Lung Transplant Recipients: Evidence-Based Recommendations

  2005cites this paper
• [Consensus document from GESITRA-SEIMC on the prevention and treatment of cytomegalovirus infection in transplanted patients].

  2005cites this paper
• A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre‐emptive therapy in thoracic organ transplant recipients

  2005cites this paper
• Complicaciones médicas del trasplante de pulmón

  2004cites this paper
• Pulmonary complications of solid organ and hematopoietic stem cell transplantation.

  2004cites this paper
• Cytomegaloviral infection and other infections related to lung allograft survival

  2004cites this paper
• Delay of CMV infection in high‐risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir

  2004cites this paper
• Medical complications of lung transplantation

  2004cites this paper
• Bronquiolitis obliterante posterior al trasplante

  2004cites this paper
• Cytomegalovirus and Lung Transplantation

  2004cites this paper
• Ganciclovir in Solid Organ Transplant Recipients: Is There a Role for Clinical Pharmacokinetic Monitoring?

  2004cites this paper
• State of the Art Pulmonary Complications of Solid Organ and Hematopoietic Stem Cell Transplantation

  2004cites this paper
• Following Universal Prophylaxis with Intravenous Ganciclovir and Cytomegalovirus Immune Globulin, Valganciclovir is Safe and Effective for Prevention of CMV Infection Following Lung Transplantation

  2004cites this paper
• Bronchiolitis Obliterans Syndrome Complicating Lung or Heart-Lung Transplantation

  2003cites this paper
• Contributions from the European Respiratory Monograph Series "lung Transplantation" Edited Post-transplant Bronchiolitis Obliterans

  2003cites this paper
• Postoperative intensive care for lung transplantation

  2003cites this paper
• Bronchiolitis obliterans syndrome complicating lung or heart-lung transplantation.

  2003cites this paper
• CONTRIBUTIONS FROM THE EUROPEAN RESPIRATORY MONOGRAPH SERIES "LUNG TRANSPLANTATION" Edited by R. D. Levy, M. Estenne, W. Weder, M.G. Cosio Number 2 in this Series Post-transplant bronchiolitis obliterans

  2003cites this paper
• Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation

  2003cites this paper
• Identification and inhibition of specific pathways leading to transplant obliterative bronchiolitis : an experimental approach in the rat

  2003cites this paper
• Bronchiolitis obliterans syndrome

  2003cites this paper
• Fungal Infections in Solid Organ Transplant Patients

  2003cites this paper
• Lung transplantation. Bronchiolitis obliterans syndrome.

  2003cites this paper
• Risk factors for bronchiolitis obliterans: a systematic review of recent publications.

  2002cites this paper
• Controversies in lung transplantation: management of cytomegalovirus infections.

  2002cites this paper
• Cytomegalovirus infections in kidney transplant patients

  2002cites this paper
• Prevention of cytomegalovirus infection and disease after lung transplantation: results using a unique regimen employing delayed ganciclovir.

  2002cites this paper
• The role of small airways in lung disease.

  2002cites this paper
• Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.

  2002cites this paper
• Infectious complications of lung transplantation

  2001cites this paper
• Epidemiology and management of infections after lung transplantation.

  2001cites this paper
• In situ characterization of human cytomegalovirus infection of bronchiolar cells in human transplanted lung

  2001cites this paper
• The role of neutrophils in the pathogenesis of obliterative bronchiolitis after lung transplantation

  2001cites this paper
• Chronic Allograft Rejection (Obliterative Bronchiolitis)

  2001cites this paper
• Rabbit antithymocyte globulin versus OKT3 induction therapy after heart-lung and lung transplantation: effect on survival, rejection, infection, and obliterative bronchiolitis

  2001cites this paper
• Clinical status of lung transplantation.

  2001cites this paper
• Improved results after lung transplantation--analysis of factors.

  2001cites this paper
• Use of cytomegalovirus immune globulin and ganciclovir for the prevention of cytomegalovirus disease in lung transplantation

  2001cites this paper
• Lung transplantation at the turn of the century.

  2001cites this paper
• Improved results after lung transplantation – analysis of factors

  2001cites this paper
• APPROACH TOWARDS INFECTIOUS PULMONARY COMPLICATIONS IN LUNG TRANSPLANT RECIPIENTS

  2001cites this paper
• Role of cytomegalovirus infection in transplant arteriosclerosis and chronic rejection

  2001cites this paper
• CMV in Solid Organ Transplantation

  2001cites this paper
• Treatment strategies for obliterative bronchiolitis

  2001cites this paper
• Cytomegalovirus infection and allograft injury

  2001cites this paper
• Rabbit antithymocyte globulin versus OKT3 induction therapy after heart‐lung and lung transplantation: effect on survival, rejection, infection, and obliterative bronchiolitis

  2001cites this paper
• A DECADE OF EXPERIENCE

  2000cites this paper
• Heart-lung versus double-lung transplantation for suppurative lung disease.

  2000cites this paper
• CT findings of pneumonia after lung transplantation.

  2000cites this paper
• Efficacy and cost effectiveness of oral ganciclovir in the prevention of cytomegalovirus disease after lung transplantation.

  1999cites this paper
• Lung and heart-lung transplantation in Hong Kong.

  1999cites this paper
• Lung transplantation.

  1999cites this paper
• Advances in lung transplantation.

  1999cites this paper